Clinical Trial Update: Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment [NA]

View source ↗

Summary

This clinical trial update describes the early feasibility study of Pivot Extend for treating tricuspid regurgitation, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• Pivot Extend

Snippet

Sponsor: Tau-MEDICAL Co., Ltd. | Conditions: Tricuspid Regurgitation (TR) | NA | Status: RECRUITING